Skip to main content
. Author manuscript; available in PMC: 2012 Jul 18.
Published in final edited form as: Ann Thorac Surg. 2011 Mar 21;91(5):1523–1530. doi: 10.1016/j.athoracsur.2011.01.056

Table 1.

Clinical characteristics of esophageal adenocarcinoma patients used in survival analysis.

Variable n (%)
Gender
 Male 38 (84)
 Female 7 (16)
N Stage
 Node-negative 24 (53)
 Node-positive 21 (47)
T Stage
 T1 20 (44)
 T2 5 (11)
 T3 18 (40)
 T4 2 (5)
Overall Stage
 I 14 (31)
 II 14 (31)
 III 14 (31)
 IV 3 (7)
Follow-up (months)
 Median 21.8
 Range 1.4 – 55.4